Prognostic impact of iliofemoral access-site calcification volume on outcomes after transcatheter aortic valve implantation

1

Transcatheter aortic valve implantation (TAVI) is a recognized treatment for severe symptomatic aortic stenosis across various surgical risk levels.
2

Pre-procedural multidetector computed tomography (CT) is essential for TAVI planning, assessing vascular anatomy and iliofemoral calcification.
3

Quantitative assessment of iliofemoral access-site calcification (IASC) volume may provide objective insights into atherosclerotic burden.
4

The study analyzed 1067 patients undergoing TAVI to evaluate the relationship between IASC volume and mortality outcomes.
5

Primary endpoints included all-cause mortality at 1, 3, and 5 years, with secondary endpoints focusing on peri-procedural complications.

Clinical Research In Cardiology

by Vivian Vij, Katja Schauwienold, Jasmin Shamekhi, Samuel Muli, Mustafa Basha, Eleftherios Markidis, Andreas Zietzer, Philip Düsing, Muntadher Al Zaidi, Marcel Weber, Lara Al-Kassou, Tobias Zeus, Victor Mauri, Matti Adam, Jörg Schröder, Stephan Baldus, Malte Kelm, Nikolaus Marx, Farhad Bakhtiary, Enzo Lüsebrink, Sebastian Zimmer, Georg Nickenig, Alexander Sedaghat, Baravan Al-Kassou
June 11, 2026

1